Finally, doctors can breathe easy over Champix's CV risk
The treatment poses no greater risk than nicotine patches, say Australian researchers
2 minutes to read
13th December 2021
Not that you can get hold of it right now, but when the shortage of varenicline resolves — slated to be in January — some potentially positive news about its safety will be to hand
For about a decade, doctors have been told to “advise patients that varenicline may cause a small increase in risk of a cardiovascular event (for example, heart attack)”, in the words of NPS MedicineWise.
The major study that spurred these warnings was a 2011 meta-analysis of 14 randomised controlled trials, with a total of
